Explore
13D/13G Activist Filings
118,898 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | AUGM | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 13G | 7.1% | 76K |
| Jan 30, 2026 | ACP | abrdn Income Credit Strategies Fund | First Trust Portfolios L.P. | 13G | 7.8% | 9.8M |
| Jan 30, 2026 | AACG | ATA Creativity Global | Ma Kevin Xiaofeng | 13D/A | 29.2% | 25.2M |
| Jan 30, 2026 | AACG | ATA Creativity Global | Jun Zhang | 13D/A | 12.4% | 10.6M |
| Jan 30, 2026 | PONY | Pony AI Inc. | TMT General Partner Ltd. | 13G/A | 4.2% | 14.6M |
| Jan 30, 2026 | FLYW | Flywire Corporation | Temasek Holdings (Private) Limited | 13G/A | 5.1% | 6.2M |
| Jan 30, 2026 | NXTC | NextCure, Inc. | Affinity Asset Advisors, LLC | 13G/A | 10.0% | 349K |
| Jan 30, 2026 | KPTI | Karyopharm Therapeutics Inc. | Affinity Asset Advisors, LLC | 13G/A | 8.6% | 1.7M |
| Jan 30, 2026 | WRAP | WRAP TECHNOLOGIES, INC. | NORRIS ELWOOD G | 13D/A | 10.7% | 5.5M |
| Jan 30, 2026 | IBIO | iBio, Inc. | Affinity Asset Advisors, LLC | 13G/A | 10.0% | 2.4M |
| Jan 30, 2026 | N/A | AEON Biopharma, Inc. | Daewoong Co.,Ltd. ("DWC") | 13D | 50.0% | 12.0M |
| Jan 30, 2026 | N/A | AEON Biopharma, Inc. | Daewoong Co.,Ltd. ("DWC") | 13D/A | 0.9% | 91K |
| Jan 30, 2026 | HOVR | New Horizon Aircraft Ltd. | Grip Investments Limited | 13G/A | 3.6% | 1.6M |
| Jan 30, 2026 | PSNL | Personalis, Inc. | Orin Hirschman | 13G/A | 3.8% | 3.4M |
| Jan 30, 2026 | IPWR | Ideal Power, Inc | Orin Hirschman | 13G/A | 5.8% | 492K |
| Jan 30, 2026 | PHGE | BIOMX INC. | Orin Hirschman | 13G/A | 0.1% | 38K |
| Jan 30, 2026 | N/A | Dror Ortho-Design, Inc. | Orin Hirschman | 13G/A | 9.9% | 95.7M |
| Jan 30, 2026 | KPRX | Kiora Pharmaceuticals, Inc. | Orin Hirschman | 13G/A | 4.9% | 193K |
| Jan 30, 2026 | VTYX | Ventyx Bioscience, Inc. | Affinity Asset Advisors, LLC | 13G/A | 9.0% | 6.5M |
| Jan 30, 2026 | VRCA | Verrica Pharmaceuticals Inc. | Affinity Asset Advisors, LLC | 13G/A | 5.5% | 884K |
| Jan 30, 2026 | LXEO | Lexeo Therapeutics, Inc. | Affinity Asset Advisors, LLC | 13G/A | 7.1% | 5.2M |
| Jan 30, 2026 | STRO | Sutro Biopharma, Inc. | Affinity Asset Advisors, LLC | 13G/A | 8.8% | 748K |
| Jan 30, 2026 | FBRX | Forte Biosciences, Inc. | Affinity Asset Advisors, LLC | 13G/A | 6.7% | 835K |
| Jan 30, 2026 | OVID | Ovid Therapeutics Inc. | Affinity Asset Advisors, LLC | 13G/A | 9.0% | 12.1M |
| Jan 30, 2026 | AVTX | Avalo Therapeutics, Inc. | Affinity Asset Advisors, LLC | 13G/A | 5.7% | 1.1M |
| Jan 30, 2026 | NBY | NovaBay Pharmaceuticals, Inc. | David E. Lazar | 13D/A | 5.0% | 6.4M |
| Jan 30, 2026 | CASI | CASI Pharmaceuticals, Inc. | WEI-WU HE, Ph.D. | 13D/A | 34.8% | 9.0M |
| Jan 30, 2026 | LNZA | LanzaTech Global, Inc. | Khosla Ventures III, L.P. | 13D/A | 0.8% | 139K |
| Jan 30, 2026 | N/A | LINCOLN BAIN CAPITAL TOTAL CREDIT FUND | LINCOLN NATIONAL CORPORATION | 13G/A | 58.9% | 14.8M |
| Jan 29, 2026 | ITRG | Integra Resources Corp. | Hillsdale Investment Management Inc. | 13G | 5.2% | 9.4M |
| Jan 29, 2026 | NEOV | NeoVolta Inc. | M.H. DAVIDSON & CO. | 13G | 0.1% | 37K |
| Jan 29, 2026 | CEPT | Cantor Equity Partners II, Inc. | RichRich Capital LLC | 13G/A | 3.0% | 724K |
| Jan 29, 2026 | AVX | AVAX One Technology Inc. | Bastion Trading Limited | 13G | 5.0% | 4.6M |
| Jan 29, 2026 | SWX | Southwest Gas Holdings, Inc. | Icahn Partners Master Fund LP | 13D/A | 2.2% | 1.6M |
| Jan 29, 2026 | PAII | Pyrophyte Acquisition Corp. II | Millennium Management LLC | 13G/A | 3.9% | 775K |
| Jan 29, 2026 | PBP | INVESCO EXCHANGE-TRADED FUND TRUST | Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 13G/A | 0.6% | 90K |
| Jan 29, 2026 | ZVIA | Zevia PBC | CDP Investissements Inc. | 13D/A | 20.1% | 13.6M |
| Jan 29, 2026 | MNRO | MONRO, INC. | GAMCO INVESTORS, INC. ET AL | 13D/A | 0.0% | 400 |
| Jan 29, 2026 | AVR | Anteris Technologies Global Corp. | Medtronic plc | 13D | 16.2% | 15.7M |
| Jan 29, 2026 | MDRX | Veradigm Inc. | Madison Avenue International LP | 13G | 6.6% | 7.2M |
| Jan 29, 2026 | EGHA | EGH Acquisition Corp. | Tenor Capital Management Company, L.P. | 13G | 7.8% | 1.2M |
| Jan 29, 2026 | NNDM | Nano Dimension Ltd. | Oramed Pharmaceuticals Inc. | 13D | 5.0% | 10.4M |
| Jan 29, 2026 | FHN | First Horizon Corporation | Integrated Core Strategies (US) LLC | 13G/A | 3.2% | 15.5M |
| Jan 29, 2026 | THM | International Tower Hill Mines Ltd. | Electrum Strategic Opportunities Fund II L.P. | 13G/A | 11.1% | 28.8M |
| Jan 29, 2026 | BCAL | California Bancorp | FJ Capital Management LLC | 13G | 6.3% | 2.1M |
| Jan 29, 2026 | CNTM | ConnectM Technology Solutions, Inc. | Geo Impex LLC | 13D | 24.5% | 33.3M |
| Jan 29, 2026 | ADAG | Adagene Inc. | Smith Vincent C | 13G/A | 8.7% | 5.1M |
| Jan 29, 2026 | HOVR | New Horizon Aircraft Ltd. | Canso Investment Counsel Ltd. | 13G/A | 25.3% | 13.3M |
| Jan 29, 2026 | MDRX | Veradigm Inc. | Mason Capital Management LLC | 13G | 5.8% | 6.3M |
| Jan 29, 2026 | CPF | CENTRAL PACIFIC FINANCIAL CORP | VM GP VII LLC | 13D/A | 0.3% | 68K |